RNA-seq maps genetic, nongenetic drivers of AML
Investigators used RNA sequencing to create a new gene activity atlas that showed how normal blood cells developed. The technique.
For CML, the science is here now access must follow
Jerald Radich and Saad Usmani discusss chronic myeloid leukemia and research funding cuts on this SOHO Insider podcast episode.
Early intervention with daratumumab for smoldering myeloma may delay disease progression
Researchers observed delayed progression to multiple myeloma (MM) in patients with smoldering MM (SMM) who were treated with single-agent daratumumab.
EMA approves OT-C001 trial in DLBCL
The European Medicines Agency (EMA) has approved an Investigational Medicinal Product Dossier (IMPD) for OT-C001.
Triplet ‘effective’ in relapsed or refractory AML
A phase 2 study found that cladribine, idarubicin, and cytarabine (CLIA) was “effective” in treating relapsed or refractory acute myeloid.
Real-world data support efficacy of IsaPd triplet in relapsed/refractory myeloma
A real-world, multicenter study supported findings from the pivotal ICARIA-MM clinical trial, showing that isatuximab, pomalidomide, and dexamethasone (IsaPd) was an.
Spain’s POC manufacturing model reimagines CAR-T delivery
While the US relies on centralized, commercial CAR-T manufacturing, Spain is taking a different approach. At Hospital Clínic de Barcelona,.
SOHO announces new half-day CME program, leadership update
As SOHO continues to expand and connect with a growing global community, we remain focused on supporting hematologic oncologists through.
Early-phase trial shows promise for refractory CD30-positive lymphoma
A CD30/CD16A bispecific antibody, AFM13, “showed encouraging preliminary safety and efficacy
ELM-1 cohort study assesses odronextamab after CAR-T therapy for DLBCL
Odronextamab monotherapy resulted in a 48.3% overall response rate in patients with diffuse large B-cell lymphoma (DLBCL) who had progressed.
Pathways & Perspectives with Charles Craddock, CBE
Dr. Craddock talks life in general and about the past and future of blood cancer treatments.
Dr. Kidson-Gerber discusses guidelines for pregnant patients with blood cancers
Giselle Kidson-Gerber, FRACP, FRCPA, a hematologist and clinical researcher at Prince of Wales Hospital and the Royal Hospital for Women,.
Early-phase study shows promise of novel CAR-T talicabtagene autoleucel for B-cell malignancies
The novel chimeric antigen receptor (CAR) T-cell therapy talicabtagene autoleucel induced durable responses in an Indian population with relapsed or.
Top Categories
POPULAR NEWS
NCI’s myeloMATCH pushes the envelope in myeloid leukemia care
January 3, 2025
Abstract submissions now open for SOHO 2025
February 14, 2025
Asciminib benefit-risk profile bests other TKIs in CML
December 10, 2024
Meetings
Editorial Board
Join Us Today and Become a Part of the SOHO Community
- Instant connections to our SOHO Communityof nearly 9,000 members
- Access to a comprehensive Resource Centerthat includes slides, publications, abstracts, videos & more
- Connection to our SOHO DocMatter Communityfor hematologic oncology discussions and education
- Free online access to our official journal, ‘Clinical Lymphoma Myeloma and Leukemia
- Free online and print subscription (US members) to our news publication,'SOHO Insider'
- Significant member-only discounts on meetings and events
- Early member-only registration and housing opportunities
- ... and much more!
SOHO Career Center
- Create a job seeker profile
- Perform intuitive searches for new jobs
- Auto-fill your resume through uploaded files
- Apply to new jobs through a streamlined workflow
- Receive email alerts when new relevant jobs are posted
To access the SOHO Career Center click the following link.
